Cancer-derived exosomal Alu RNA promotes colorectal cancer progression

Area of Science:

• Molecular Biology
• Oncology
• Immunology

Background:

• Inflammation is integral to cancer progression.
• The role of inflammasomes, particularly NLRP3, in cancer remains incompletely understood.
• Alu RNA is an endogenous nucleic acid known to activate the NLRP3 inflammasome.

Purpose of the Study:

• To investigate the role of Alu RNA in colorectal cancer (CRC) pathogenesis.
• To determine if Alu RNA induces epithelial-to-mesenchymal transition (EMT) via NLRP3 inflammasome activation.
• To explore the potential of exosomal Alu RNA as a diagnostic biomarker for CRC.

Main Methods:

• Investigated Alu RNA's effect on CRC cells, focusing on NLRP3 inflammasome activation and IL-1β release.
• Examined the role of exosomes in the transport of Alu RNA to CRC cells.
• Assessed the correlation between Alu RNA expression/exosomal levels and CRC progression in patient data and preclinical models.

Main Results:

• Alu RNA induces EMT in CRC cells through NLRP3 inflammasome activation and IL-1β release.
• Exosomes mediate the storage, transport, and transfer of Alu RNA to CRC cells, promoting invasion, metastasis, and EMT.
• Increased Alu RNA expression correlates with NLRP3 priming in human CRC patients.
• Circulating exosomal Alu RNA levels correlate with CRC progression in a preclinical model.

Conclusions:

• Alu RNA directly contributes to colorectal cancer pathogenesis by activating the NLRP3 inflammasome.
• Exosomal Alu RNA plays a significant role in promoting CRC tumorigenesis, invasion, and metastasis.
• Alu RNA in circulating exosomes presents a promising noninvasive biomarker for CRC diagnosis and progression monitoring.